MedTrace Logo

Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance

NCT03509441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2023-03-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate the relationship between insulin resistance (IR) and myocardial tissue abnormalities. The study will focus on a patient population, South Asians, with a high prevalence of IR.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Rajesh Dash, MD, PhD · Stanford University

  • Abha Khandelwal, MD · Stanford University

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-15
Primary Completion
2019-09-11
Completion
2019-11-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03509441 on ClinicalTrials.gov